These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19211358)

  • 1. [Epidemiology, prevention, screening and diagnosis of hepatocellular carcinoma].
    Trinchet JC; Alperovitch A; Bedossa P; Degos F; Hainaut P; Beers BV
    Bull Cancer; 2009 Jan; 96(1):35-43. PubMed ID: 19211358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology and diagnosis of hepatocellular carcinomas in cirrhosis].
    Duvoux C
    Ann Chir; 1998; 52(6):511-7. PubMed ID: 9752500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma development in cirrhosis.
    Okuda H
    Best Pract Res Clin Gastroenterol; 2007; 21(1):161-73. PubMed ID: 17223503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
    Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
    Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma: epidemiology, risk factors, and screening.
    Sherman M
    Semin Liver Dis; 2005; 25(2):143-54. PubMed ID: 15918143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral hepatitis and hepatocellular carcinoma.
    Marrero CR; Marrero JA
    Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis].
    Bolondi L; Gaiani S; Casali A; Serra C; Piscaglia F
    Radiol Med; 1997; 94(1-2):4-7. PubMed ID: 9424649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.
    Chalasani N; Said A; Ness R; Hoen H; Lumeng L
    Am J Gastroenterol; 1999 Aug; 94(8):2224-9. PubMed ID: 10445554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatocarcinoma: epidemiologic and clinical evaluation of 90 patients].
    Grassi M; Fontana M; Nocchi S; Albiani B; Labbadia G; Raffa S
    Clin Ter; 2000; 151(2):87-92. PubMed ID: 10876975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of cirrhosis is the best measure against hepatocellular cancer].
    Kaczynski J
    Lakartidningen; 1999 Jan; 96(4):338-41. PubMed ID: 10024824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in prevention and diagnosis of hepatocellular carcinoma.
    Spangenberg HC; Thimme R; Blum HE
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):425-33. PubMed ID: 19072390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma.
    Hayashi PH; Di Bisceglie AM
    Med Clin North Am; 2005 Mar; 89(2):345-69. PubMed ID: 15656930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue].
    Trinchet JC; Nahon P; Ganne-Carrie N
    Rev Prat; 2013 Feb; 63(2):222-5. PubMed ID: 23513790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
    Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
    Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes.
    Tsega E; Nordenfelt E; Hansson BG; Mengesha B; Lindberg J
    Ethiop Med J; 1992 Apr; 30(2 Suppl):1-33. PubMed ID: 1319901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
    Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
    Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
    Cucchetti A; Piscaglia F; Caturelli E; Benvegnù L; Vivarelli M; Ercolani G; Cescon M; Ravaioli M; Grazi GL; Bolondi L; Pinna AD
    Ann Surg Oncol; 2009 Feb; 16(2):413-22. PubMed ID: 19034578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.